Treatment of Patients with Cancer in a Secondary Hospital in Korea.
10.14475/kjhpc.2018.21.3.84
- Author:
Myoung Kyun SON
1
Author Information
1. Department of Internal Medicine, Kangnam General Hospital, Yongin, Korea. meonggu@naver.com
- Publication Type:Original Article
- Keywords:
Neoplasms;
Secondary care centers;
Tertiary care centers;
Palliative care;
Resuscitation orders
- MeSH:
Comorbidity;
Drug Therapy;
Electronic Health Records;
Hospices;
Humans;
Korea*;
Length of Stay;
Long-Term Care;
Nursing Homes;
Palliative Care;
Radiotherapy;
Referral and Consultation;
Resuscitation Orders;
Retrospective Studies;
Secondary Care Centers;
Tertiary Care Centers
- From:Korean Journal of Hospice and Palliative Care
2018;21(3):84-91
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study aims to investigate treatment of cancer patients at a secondary hospital. METHODS: A retrospective analysis was performed with electronic medical records of cancer patients admitted to a secondary hospital from January 1, 2009 through September 31, 2017. RESULTS: A total of 223 patients were studied. Sixty-nine patients were hospitalized for supportive care after receiving a surgery, chemotherapy, and radiotherapy at a tertiary hospital, 58 patients for other supportive care, 53 patients for symptom control, 16 patients with a decision not to take active cancer treatment, and 27 patients for treatment of cancer that was diagnosed during their hospital stay. Among 75 patients who were discharged to other institutions, 50 were transferred to tertiary hospitals, 10 to long-term care hospitals, eight to hospice hospitals, four to nursing homes and two to secondary hospitals. Comorbidities were found in 120 patients (53.8%). For patients who consulted with more than one department, more consultations were for non-cancer diseases than cancer. Seventy-three patients had a do-not-resuscitate order. CONCLUSION: For treatment of cancer patients, it is needed to establish a cooperation system among medical institutions and provide comprehensive management including treatment of comorbidities.
